“The theme of this year, I felt had the correct balance of large & small molecule, reg and non-reg as well as Bioanalysis, Biotransformation and Biomarkers.” -APA Attendee

“I was particularly impressed by the combination of biotrans and bioanalytical subject matter - this link is crucial to my mind.” -APA Attendee

“Keep going on the combination of ADME and bioanalytical sciences for large and small molecules. I was impressed with the conference content this year.” -APA Attendee

“Liked the overall mix with more large molecule presentaions and still having biotransformation.” -APA Attendee

“Continue to have FDA updates what it is looking for on the regulated bioanalysis field.” -APA Attendee

“Appreciate the multiple speakers from the FDA. Very nice to see more than one representative from the FDA.” -APA Attendee

“I thought the FDA participation was well suited to the meeting and an important addition.” -APA Attendee

“FDA participation has always been quality including this year.” -APA Attendee

“Boston society staffs are very friendly and helpful.” -APA Attendee

“The APA conference is excellent, and I am hearing from colleagues that it is the conference of choice. It has gained popularity due to the high quality of speakers and topics that are presented each year.” -APA Attendee

“The content all hinges on the quality of speakers selected and the dispersion of topics. Really liked the broad representation of FDA speakers facilitated by the meeting proximity to their offices. Having that opportunity for direct scientific and policy discussion is a major selling point for this meeting.” -APA Attendee

“I was very impressed with my first APA!” -APA Attendee

“I just want to say that it is really impressive that you managed to get so many FDA officals to speak at the meeting.” -APA Attendee

“As I am a biotransformation person and leader of MIST activities in my company, this session was extremely valuable. Good spread of speakers over Pharma.” -APA Attendee

September 16-18, 2013

(September 15: Short Coures Only)

The Boston Park Plaza Hotel & Towers
50 Park Plaza at Arlington Street
Boston, MA 02116-3912
800-225-2008

Plenary talk: Brian Booth, FDA

"New BA Guidance"

Plernary talk: Michael Skelly, FDA

"Similarities & Differences in Audits of Bioequivalence Studies by FDA and other Regulatory Authorities"

Plenary talk: Dr. James Burns, Sanofi Boston R&D Hub

"New Ways of Conducting R&D in Big Pharma"

For Parking Information click here.

Sessions

Regulated Bioanalysis

Discovery Bioanalysis & New Technologies

Biotransformation

Registration

Click here to register for the APA 2013 conference online.

Conference venue:
The Boston Park Plaza Hotel & Towers
50 Park Plaza at Arlington Street

Bosotn, MA 02116-3912

800-225-2008

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

September 16-18, 2013

Sessions

Registration

The Boston Society

Updates